ALB and hepatocellular carcinoma: The IFN-free DAA group was older, consisted of more women, and had longer duration from the date of last HCC treatment to antiviral therapy, lower leukocyte count, lower hemoglobin level, lower platelet count, lower albumin level, and higher Fib-4 index.